PharmaTher Holdings Ltd. (OTCQB: PHRRF | CSE: PHRM), a leader in specialty ketamine pharmaceuticals, today announced that the Phase 1/2 clinical Study...
Oral psilocybin film-strips to treat could conduct the first-in-human clinical study as soon as next year. The post Revive Therapeutics Gets Nod From FDA,...
Blackhawk Growth Corp. (CSE:BLR | Frankfurt:0JJ) is pleased to announce that its wholly-owned subsidiary, MindBio Therapeutics, will be presenting its...
The psychedelics industry is attracting more attention from less scrupulous operators who see the reward as worth the risk. The post Illicit Psychedelics...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...
Wellbeing Digital Sciences Inc., (NEO: MEDI | OTC: KONEF | FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation...
The article New Survey Shows Psychedelic Use At Record High was originally published on Microdose. Psychedelia has been busy stamping its imprint on the...
Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) posted positive results as revenue rose along with patients — showing the growing demand for psychedelics-centered...
Numinus Updates On New Acquisition’s Integration And Provides Client Financing Options Numinus Wellness Inc. (OTCQX: NUMIF) recently acquired psychedelics...
In collaboration with the Manke Lab at UMass Dartmouth and the Designer Drug Research Unit at the National Institute on Drug Abuse Intramural Research...